Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer
Chia‐Yi Lin, Kuo‐Yen Huang, Yi‐Chun Lin, Shuenn‐Chen Yang, Wei-Chia Chung, Yih‐Leong Chang, Jin‐Yuan Shih, Chao‐Chi Ho, Chih-An Lin, Chih-Chun Shih, Ya‐Hsuan Chang, Shih-Han Kao, Pan‐Chyr Yang
Topics & Concepts
T790MVorinostatEpidermal growth factor receptorCancer researchMedicineLung cancerPharmacologyEGFR inhibitorsChemistryCancerHistone deacetylaseGefitinibInternal medicineBiochemistryHistoneGeneLung Cancer Treatments and MutationsHistone Deacetylase Inhibitors ResearchPeptidase Inhibition and Analysis